BioSpace News Archive

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2023.

Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2023 after the market close on Thursday, August 3, 2023.

Akari Therapeutics, Plc today announced that the European Commission granted orphan drug designation to nomacopan as a treatment in hematopoietic stem cell transplantation following the European Medicines Agency positive opinion in June.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, Ph.D., Bionano’s president and chief executive officer will present at the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023.

Avalyn Pharma Inc. announced that CEO Lyn Baranowski will participate in the 43rd annual Canaccord Genuity Growth Conference, which is being held August 7-10, 2023 in Boston, MA.

Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three months ended June 30, 2023.

Quoin Pharmaceuticals Ltd. announced today that the Company plans to release its second quarter 2023 financial results after the market closes on Wednesday, August 2, 2023.

Talis Biomedical Corporation (Nasdaq: TLIS) today announced new data supporting the development of its planned CT/NG/TV and vaginal infection panels.

Biora Therapeutics, Inc. today announced progress with its latest clinical device performance study, evaluating the device function and safety of its NaviCap™ targeted oral delivery platform.

Telavant, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics to help patients living with inflammatory and fibrotic diseases, announced today the initiation of the TAHOE study, a Phase 2 clinical trial of RVT-3101 for the treatment of moderate to severely active CD, with first patient dosed.